Literature DB >> 1567045

Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans.

Y Kobayashi1, R Ochiai, J Takeda, H Sekiguchi, K Fukushima.   

Abstract

Serum and urinary concentrations of inorganic fluoride were measured before and after sevoflurane anesthesia in 10 patients without renal disease, who were scheduled for surgery lasting 13.4 +/- 0.9 h (mean +/- SE). The mean concentration of serum inorganic fluoride reached a maximal value of 42.5 +/- 4.5 mumol/L at the end of anesthesia. However, 5 of 10 patients had serum inorganic fluoride concentrations that exceeded 50 mumol/L (i.e., the nephrotoxic dose). A positive correlation was found between serum inorganic fluoride concentration and anesthetic dose. The largest urinary excretion of inorganic fluoride was 1804 +/- 378 mumol/day in the first postoperative day and rapidly decreased thereafter. We concluded that lengthy sevoflurane anesthesia created serum inorganic fluoride concentrations that could influence renal function, although nephrotoxicity was not demonstrated in our biochemical study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567045     DOI: 10.1213/00000539-199205000-00022

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Sevoflurane anesthesia for renal transplanted patient-comparison with normal renal function subjects.

Authors:  Tomoki Nishiyama; Masaki Nagase
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

2.  Correlation between renal function and pharmacokinetic parameters of inorganic fluoride following sevoflurane anesthesia.

Authors:  Tomoki Nishiyama; Narushi Toda
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

3.  Studies of the mechanism of nephrotoxicity of compound A in rats.

Authors:  J L Martin; L Kandel; M J Laster; R L Kerschmann; E I Eger
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 4.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 5.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 6.  Renal toxicity with sevoflurane: a storm in a teacup?

Authors:  B A Gentz; T P Malan
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Exposure of neonatal mice to Sevoflurane may induce male germ cell apoptosis in testicular tissue after puberty.

Authors:  Maryam Nezhad Sistani; Anahid Maleki; Maryam Salimi; Marefat Ghaffari Novin; Hamid Nazarian
Journal:  Int J Reprod Biomed (Yazd)       Date:  2017-08

8.  Kidney function in living donors undergoing nephrectomy by sevoflurane or desflurane anesthesia.

Authors:  Min-Soo Kim; Jeong-Rim Lee; Myoung-Soo Kim; Sung-Yeon Ham; Seung-Ho Choi
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.